Combined CABG and Stem-Cell Transplantation for Heart Failure
NCT00418418 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2008-08-19
Summary
This is a prospective double blind trial of intraoperative transmyocardial bone marrow-derived mesenchymal cell transplantation vs placebo in patients with low left ventricular ejection fraction scheduled to coronary bypass operation.
Conditions
Interventions
- PROCEDURE
-
Coronary bypass operation
Coronary bypass operation is performed via sternotomy during cardiac arrest.
- PROCEDURE
-
Bone marrow aspiration (crista iliaca)
The bone marrow is aspirated from the iliac crest (100ml). During the operation the aspirate is transported to the stem cell laboratory, where the sample is centrifugated through Ficoll(Registered Trademark).
- BIOLOGICAL
-
Intramyocardial mesenchymal stem cell transplantation
During the cardiac arrest, stem cells are directly injected to myocardium. The amount of the cells varies individually (5-1000 x 10e6 cells), the cells are diluted in autologous serum (5 ml)
- BIOLOGICAL
-
Intramyocardial injection of autologous serum
Intramyocardial injection of autologous serum is injected during cardiac arrest
Sponsors & Collaborators
-
University of Helsinki
lead OTHER
Principal Investigators
-
Ari Harjula, MD; PhD · Department of Cardiothoracic Surgery, Helsinki University MeilahtiHospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-10-31
- Primary Completion
- 2009-12-31
- Completion
- 2010-12-31
Countries
- Finland
Study Locations
More Related Trials
-
MSCs for Prevention of MI-induced HF
NCT05043610 ·Status: COMPLETED ·Phase: PHASE3
-
Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart Failure
NCT05566600 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells for Dilated Cardiomyopathy
NCT00743639 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery
NCT00950274 ·Status: TERMINATED ·Phase: PHASE3
-
Autologous Atrial Appendage Derived Cells in the Treatment of Heart Failure
NCT02672163 ·Status: COMPLETED ·Phase: NA
-
By Pass Surgery With Stem Cell Therapy in Chronic Ischemic Cardiopathy
NCT00690209 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy
NCT01739777 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Use of Bone Marrow Derived Stem Cell and G-CSF With Circulatory Assistance in the Treatment of DCM
NCT03572660 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy
NCT01302171 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of Hypoxia-Stressed Bone Marrow Mononuclear Cell Transplantation to Treat Heart Diseases
NCT01234181 ·Status: UNKNOWN ·Phase: NA
-
Autologous Bone Marrow Mononuclear Cells in the Combined Treatment of Coronary Heart Disease
NCT02059512 ·Status: COMPLETED ·Phase: NA
-
The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Non-ischemic Heart Failure
NCT04325594 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stem Cell Therapy in Chronic Ischemic Heart Failure
NCT00235417 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Stem Cell Treatment for Adults With Ischemic Cardiomyopathy (The FOCUS Study)
NCT00824005 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Adipose Derived Stem Cells for Congestive Heart Failure
NCT01502514 ·Status: WITHDRAWN ·Phase: PHASE1
-
Stem Cell Injection to Treat Heart Damage During Open Heart Surgery
NCT01557543 ·Status: TERMINATED ·Phase: PHASE1
-
Stem Cell Implantation in Patients Undergoing CABG
NCT01721902 ·Status: TERMINATED ·Phase: PHASE1
-
Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy
NCT01957826 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Progenitor Cell Therapy in Dilative Cardiomyopathy
NCT00284713 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction
NCT00874354 ·Status: COMPLETED ·Phase: PHASE1
-
Stem Cells and Resynchronization Cardiac
NCT00800657 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease
NCT05147766 ·Status: TERMINATED ·Phase: PHASE1
-
Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction
NCT04421274 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Stem Cell Injection in Cancer Survivors
NCT02509156 ·Status: COMPLETED ·Phase: PHASE1
-
Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Ischemic Cardiomyopathy
NCT01946048 ·Status: UNKNOWN ·Phase: PHASE1